These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19337287)

  • 1. Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis.
    Phillips K; Byrne-Dugan C; Batterson E; Seibold JR
    Nat Rev Rheumatol; 2009 Apr; 5(4):225-8. PubMed ID: 19337287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interstitial lung disease in systemic sclerosis].
    Mouthon L; Berezné A; Brauner M; Kambouchner M; Guillevin L; Valeyre D
    Presse Med; 2006 Dec; 35(12 Pt 2):1943-51. PubMed ID: 17159721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma.
    Simms RW
    Arthritis Rheumatol; 2020 Sep; 72(9):1415-1426. PubMed ID: 32562363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis-associated interstitial lung disease.
    Perelas A; Silver RM; Arrossi AV; Highland KB
    Lancet Respir Med; 2020 Mar; 8(3):304-320. PubMed ID: 32113575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
    Tashkin DP; Roth MD; Clements PJ; Furst DE; Khanna D; Kleerup EC; Goldin J; Arriola E; Volkmann ER; Kafaja S; Silver R; Steen V; Strange C; Wise R; Wigley F; Mayes M; Riley DJ; Hussain S; Assassi S; Hsu VM; Patel B; Phillips K; Martinez F; Golden J; Connolly MK; Varga J; Dematte J; Hinchcliff ME; Fischer A; Swigris J; Meehan R; Theodore A; Simms R; Volkov S; Schraufnagel DE; Scholand MB; Frech T; Molitor JA; Highland K; Read CA; Fritzler MJ; Kim GHJ; Tseng CH; Elashoff RM;
    Lancet Respir Med; 2016 Sep; 4(9):708-719. PubMed ID: 27469583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes.
    Yokoyama T; Sakamoto T; Shida N; Kinoshita M; Kunou Y; Karukaya R; Takamatsu M; Aizawa H
    J Intensive Care Med; 2005; 20(3):160-3. PubMed ID: 15888904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural course of progressive systemic sclerosis patients with interstitial lung involvement.
    Benan M; Hande I; Gul O
    Clin Rheumatol; 2007 Mar; 26(3):349-54. PubMed ID: 16636936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based management of rapidly progressing systemic sclerosis.
    Khanna D; Denton CP
    Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):387-400. PubMed ID: 20534372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral Optic Neuropathy in Association with Diffuse Cutaneous Systemic Sclerosis with Interstitial Lung Disease.
    Prasad N; Dubey A; Kumar K
    Ocul Immunol Inflamm; 2024 Jul; 32(5):784-787. PubMed ID: 37043627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease in systemic sclerosis.
    Cheema GS; Quismorio FP
    Curr Opin Pulm Med; 2001 Sep; 7(5):283-90. PubMed ID: 11584177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapidly progressive fatal interstitial lung disease in a patient with an overlap syndrome of systemic lupus erythematosus and systemic sclerosis].
    Sacnun MP; Ferrer J; Ferrer M; Pons-Estel BA
    Reumatol Clin; 2011; 7(1):61-7. PubMed ID: 21794782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Sclerosis and Pulmonary Disease.
    Ngo K
    Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
    Chong WH; Saha BK; Beegle S
    Am J Med Sci; 2021 Apr; 361(4):526-533. PubMed ID: 33386120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arthritis Mutilans in Systemic Sclerosis.
    Abignano G; Mennillo GA; Lettieri G; Padula A; McGonagle D; D'Angelo S
    Arthritis Rheumatol; 2019 Jan; 71(1):120. PubMed ID: 30221850
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis.
    Ueda T; Sakagami T; Kikuchi T; Takada T
    Respir Investig; 2018 Jan; 56(1):14-20. PubMed ID: 29325675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute interstitial pneumonitis. Case series and review of the literature.
    Vourlekis JS; Brown KK; Cool CD; Young DA; Cherniack RM; King TE; Schwarz MI
    Medicine (Baltimore); 2000 Nov; 79(6):369-78. PubMed ID: 11144035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease.
    Miura Y; Saito T; Fujita K; Tsunoda Y; Tanaka T; Takoi H; Yatagai Y; Rin S; Sekine A; Hayashihara K; Nei T; Azuma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):235-8. PubMed ID: 25363224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascending aortic aneurysm in a man with scleroderma.
    Attaran RR; Guarraia D
    Clin Rheumatol; 2007 Jun; 26(6):1027-8. PubMed ID: 16572286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.